MedPath

A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy

Phase 4
Conditions
Infection
Prostatic Diseases
Misadventure During Aspirating Needle Biopsy
Interventions
Registration Number
NCT02245334
Lead Sponsor
Seoul National University Hospital
Brief Summary

To assess the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy

Detailed Description

the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
1578
Inclusion Criteria
  • who undergo transrectal prostate biopsy
Exclusion Criteria
  • patients who refuse to be included, patients who have hypersensitivity to iodine, patients who have abnormal thyroid function, patients who do not visit follow-up, patients who have received prior radioactive-iodine therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Povidone-iodinePovidone-Iodinepovidone iodine pill
Primary Outcome Measures
NameTimeMethod
Number of participants with febrile infection1 week

consider fever over 38 degree celsius or admission due to fever

Secondary Outcome Measures
NameTimeMethod
voiding questionnaire1-2 week

check International Prostate Symptom Score (IPSS)

sexual function questionnaire1-2 week

International Index of Erectile Function-5 (IIEF-5)

quality of life questionnaire1-2 week

European Organization for Research and Treatment fo Cancer (EORTC) Quality of life Questionnaire (QLQ)-C30 questionnaire

Trial Locations

Locations (1)

Department of Urology, Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyunggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath